Derenzini M - Search Results

1

c-erbB-2 over-expression in amplified and non-amplified breast carcinoma samples.

Farabegoli F, Ceccarelli C, Santini D, Baldini N, Taffurelli M, Marrano D, Treré D, Derenzini M. Farabegoli F, et al. Among authors: derenzini m. Int J Cancer. 1999 Jun 21;84(3):273-7. doi: 10.1002/(sici)1097-0215(19990621)84:3<273::aid-ijc13>3.0.co;2-7. Int J Cancer. 1999. PMID: 10371346

2

Chromosome 1 aneusomy with 1p36 under-representation is related to histologic grade, DNA aneuploidy, high c-erb B-2 and loss of bcl-2 expression in ductal breast carcinoma.

Farabegoli F, Ceccarelli C, Santini D, Trerè D, Baldini N, Taffurelli M, Derenzini M. Farabegoli F, et al. Among authors: derenzini m. Int J Cancer. 1996 Oct 21;69(5):381-5. doi: 10.1002/(SICI)1097-0215(19961021)69:5<381::AID-IJC5>3.0.CO;2-1. Int J Cancer. 1996. PMID: 8900371

3

Cell proliferation in breast cancer is a major determinant of clinical outcome in node-positive but not in node-negative patients.

Treré D, Ceccarelli C, Migaldi M, Santini D, Taffurelli M, Tosti E, Chieco P, Derenzini M. Treré D, et al. Among authors: derenzini m. Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):314-23. doi: 10.1097/00129039-200609000-00010. Appl Immunohistochem Mol Morphol. 2006. PMID: 16932023

4

Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure.

Derenzini M, Donati G, Mazzini G, Montanaro L, Vici M, Ceccarelli C, Santini D, Taffurelli M, Treré D. Derenzini M, et al. Clin Cancer Res. 2008 Apr 1;14(7):2199-209. doi: 10.1158/1078-0432.CCR-07-2065. Clin Cancer Res. 2008. PMID: 18381962

5

Relationship between dyskerin expression and telomerase activity in human breast cancer.

Montanaro L, Calienni M, Ceccarelli C, Santini D, Taffurelli M, Pileri S, Treré D, Derenzini M. Montanaro L, et al. Among authors: derenzini m. Cell Oncol. 2008;30(6):483-90. doi: 10.3233/clo-2008-0436. Cell Oncol. 2008. PMID: 18936525 Free PMC article.

6

Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation.

Montanaro L, Calienni M, Bertoni S, Rocchi L, Sansone P, Storci G, Santini D, Ceccarelli C, Taffurelli M, Carnicelli D, Brigotti M, Bonafè M, Treré D, Derenzini M. Montanaro L, et al. Among authors: derenzini m. Cancer Res. 2010 Jun 1;70(11):4767-77. doi: 10.1158/0008-5472.CAN-09-4024. Epub 2010 May 25. Cancer Res. 2010. PMID: 20501855

7

Genetic pathways in the evolution of breast ductal carcinoma in situ.

Farabegoli F, Champeme MH, Bieche I, Santini D, Ceccarelli C, Derenzini M, Lidereau R. Farabegoli F, et al. Among authors: derenzini m. J Pathol. 2002 Mar;196(3):280-6. doi: 10.1002/path.1048. J Pathol. 2002. PMID: 11857490

8

AgNORs in breast tumours.

Ceccarelli C, Trerè D, Santini D, Taffurelli M, Chieco P, Derenzini M. Ceccarelli C, et al. Among authors: derenzini m. Micron. 2000 Apr;31(2):143-9. doi: 10.1016/s0968-4328(99)00071-2. Micron. 2000. PMID: 10588060

9

The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status.

Derenzini M, Ceccarelli C, Santini D, Taffurelli M, Treré D. Derenzini M, et al. J Clin Pathol. 2004 Jul;57(7):755-61. doi: 10.1136/jcp.2003.015917. J Clin Pathol. 2004. PMID: 15220371 Free PMC article.

10

Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study.

Farabegoli F, Baldini N, Santini D, Ceccarelli C, Taffurelli M, Treré D, Derenzini M. Farabegoli F, et al. Among authors: derenzini m. Clin Mol Pathol. 1996 Apr;49(2):M98-M103. doi: 10.1136/mp.49.2.m98. Clin Mol Pathol. 1996. PMID: 16696058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters